Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol dose comparison for prevention of postoperative nausea and vomiting after spinal discectomy
IRCT20160307026950N21Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propofol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Nausea occurrence and severity, Vomiting occurrence and 10 more. Started Mar 2018; status: completed.
02
Drugs
propofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20160307026950N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N21.